Vascular pathways: microangiopathy, ischemic lesions. Metabolic dysregulation: hyperglycemia-induced oxidative stress, insulin resistance. Shared risk factors: hypertension, dyslipidemia. This evidence concerns the gene INS and hypertensive disorder.